FY2023-24: Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease Grant

FY2023-24: Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease .

date/time interval

  • July 1, 2023 - June 30, 2034

awarded by

sponsor award ID

  • Award Recog - FY23-24_BOG-Bapt-COM_03/15/2024

contributor